Skinvisible (SKVI) Operating Income (2016 - 2026)
Skinvisible's Operating Income history spans 16 years, with the latest figure at -$114169.0 for Q4 2025.
- On a quarterly basis, Operating Income rose 42.55% to -$114169.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$496315.0, a 15.82% increase, with the full-year FY2025 number at -$496315.0, up 15.82% from a year prior.
- Operating Income hit -$114169.0 in Q4 2025 for Skinvisible, down from -$106057.0 in the prior quarter.
- Over the last five years, Operating Income for SKVI hit a ceiling of $159520.0 in Q2 2021 and a floor of -$198743.0 in Q4 2024.
- Historically, Operating Income has averaged -$81331.6 across 5 years, with a median of -$115942.5 in 2022.
- Biggest five-year swings in Operating Income: soared 1813.37% in 2021 and later tumbled 1519.34% in 2022.
- Tracing SKVI's Operating Income over 5 years: stood at $147540.0 in 2021, then plummeted by 179.79% to -$117716.0 in 2022, then dropped by 15.99% to -$136538.0 in 2023, then plummeted by 45.56% to -$198743.0 in 2024, then skyrocketed by 42.55% to -$114169.0 in 2025.
- Business Quant data shows Operating Income for SKVI at -$114169.0 in Q4 2025, -$106057.0 in Q3 2025, and -$136237.0 in Q2 2025.